Worried About Teladoc's Post-Pandemic Future? This Statistic Suggests You Shouldn't Be
The coronavirus pandemic offered Teladoc Health (NYSE: TDOC) a significant boost in 2020. When scheduling face-to-face medical appointments was risky, difficult -- or sometimes, impossible -- patients flocked to virtual medical appointments. Revenue climbed by triple-digit percentages from quarter to quarter, and its share price surged by 138% for the year.
But this year, investors began to worry about the company's future. The concern was that Teladoc's business would lose a lot of steam as the pandemic waned and patients could comfortably return to doctors' offices. As a result, Teladoc's share price has slipped by more than 20% year to date. But these concerns look exaggerated to me -- especially when considering one key number in Teladoc's second-quarter earnings report.
Image source: Getty Images.
Source Fool.com
